Skip to main content
Top
Published in: Osteoporosis International 11/2022

Open Access 11-06-2022 | Osteoporosis | Review

Supporting patients to get the best from their osteoporosis treatment: a rapid realist review of what works, for whom, and in what circumstance

Authors: Z. Paskins, O. Babatunde, A. Sturrock, L. S. Toh, R. Horne, I. Maidment, on behalf of the Effectiveness Working Group of the Royal Osteoporosis Society Osteoporosis, Bone Research Academy

Published in: Osteoporosis International | Issue 11/2022

Login to get access

Abstract

Summary

Systematic reviews that examine effectiveness of interventions to improve medicines optimisation do not explain how or why they work. This realist review identified that interventions which effectively optimise medicines use in osteoporosis include opportunities to address patients’ perceptions of illness and treatment and/or support primary care clinician decision making.

Introduction

In people with osteoporosis, adherence to medicines is poorer than other diseases and patients report follow-up is lacking, and multiple unmet information needs. We conducted a rapid realist review to understand what contextual conditions and mechanisms enable interventions to support osteoporosis medication optimisation.

Methods

A primary search identified observational or interventional studies which aimed to improve medicines adherence or optimisation; a supplementary second search identified research of any design to gain additional insights on emerging findings. Extracted data was interrogated for patterns of context-mechanism-outcome configurations, further discussed in team meetings, informed by background literature and the Practicalities and Perception Approach as an underpinning conceptual framework.

Results

We identified 5 contextual timepoints for the person with osteoporosis (identifying a problem; starting medicine; continuing medicine) and the practitioner and healthcare system (making a diagnosis and giving a treatment recommendation; reviewing medicine). Interventions which support patient-informed decision making appear to influence long-term commitment to treatment. Supporting patients’ practical ability to adhere (e.g. by lowering treatment burden and issuing reminders) only appears to be helpful, when combined with other approaches to address patient beliefs and concerns. However, few studies explicitly addressed patients’ perceptions of illness and treatment. Supporting primary care clinician decision making and integration of primary and secondary care services also appears to be important, in improving rates of treatment initiation and adherence.

Conclusions

We identified a need for further research to identify a sustainable, integrated, patient-centred, and cost- and clinically effective model of long-term care for people with osteoporosis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Borgstrom F, Lekander I, Ivergard M et al (2013) The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)–quality of life during the first 4 months after fracture. Osteoporos Int 24:811–823PubMedCrossRef Borgstrom F, Lekander I, Ivergard M et al (2013) The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)–quality of life during the first 4 months after fracture. Osteoporos Int 24:811–823PubMedCrossRef
2.
go back to reference Cooper C (1997) The crippling consequences of fractures and their impact on quality of life. Am J Med 103:12S-17SPubMedCrossRef Cooper C (1997) The crippling consequences of fractures and their impact on quality of life. Am J Med 103:12S-17SPubMedCrossRef
3.
go back to reference NICE (2009) Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. National Institute for Health and Care Excellence, London NICE (2009) Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. National Institute for Health and Care Excellence, London
4.
go back to reference Papaioannou A, Ioannidis G, Adachi JD et al (2003) Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database. Osteoporos Int 14:808–813PubMedCrossRef Papaioannou A, Ioannidis G, Adachi JD et al (2003) Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database. Osteoporos Int 14:808–813PubMedCrossRef
5.
go back to reference Seeman E, Compston J, Adachi J et al (2007) Non-compliance: the Achilles’ heel of anti-fracture efficacy. Osteoporos Int 18:711–719PubMedCrossRef Seeman E, Compston J, Adachi J et al (2007) Non-compliance: the Achilles’ heel of anti-fracture efficacy. Osteoporos Int 18:711–719PubMedCrossRef
6.
go back to reference Hiligsmann M, Cornelissen D, Vrijens B et al (2019) Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF). Osteoporos Int 30(11):2155–2165PubMedPubMedCentralCrossRef Hiligsmann M, Cornelissen D, Vrijens B et al (2019) Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF). Osteoporos Int 30(11):2155–2165PubMedPubMedCentralCrossRef
7.
go back to reference Royal Pharmaceutical Society (2013) Medicines optimisation: helping patients to make the most of medicines. Good practice guide for healthcare professionals in England. Royal Pharmaceutical Society, London Royal Pharmaceutical Society (2013) Medicines optimisation: helping patients to make the most of medicines. Good practice guide for healthcare professionals in England. Royal Pharmaceutical Society, London
9.
go back to reference Cornelissen D, de Kunder S, Si L, European Society for Clinical and Economic Aspect of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) et al (2020) Interventions to improve adherence to anti-osteoporosis medications: an updated systematic review. Osteoporos Int 31(9):1645–1669PubMedPubMedCentralCrossRef Cornelissen D, de Kunder S, Si L, European Society for Clinical and Economic Aspect of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) et al (2020) Interventions to improve adherence to anti-osteoporosis medications: an updated systematic review. Osteoporos Int 31(9):1645–1669PubMedPubMedCentralCrossRef
10.
go back to reference Gleeson T, Iversen M, Avorn J et al (2009) Interventions to improve adherence and persistence with osteoporosis medications: a systematic literature review. Osteoporos Int 20:2127–2134PubMedPubMedCentralCrossRef Gleeson T, Iversen M, Avorn J et al (2009) Interventions to improve adherence and persistence with osteoporosis medications: a systematic literature review. Osteoporos Int 20:2127–2134PubMedPubMedCentralCrossRef
11.
go back to reference Pawson R (2002) Evidence-based policy: the promise of realist synthesis’. Evaluation 8(3):340–358CrossRef Pawson R (2002) Evidence-based policy: the promise of realist synthesis’. Evaluation 8(3):340–358CrossRef
13.
go back to reference Paskins Z, Crawford-Manning F, Cottrell E et al (2020) Acceptability of bisphosphonates among patients, clinicians and managers: a systematic review and framework synthesis. BMJ Open 10(11):e040634PubMedPubMedCentralCrossRef Paskins Z, Crawford-Manning F, Cottrell E et al (2020) Acceptability of bisphosphonates among patients, clinicians and managers: a systematic review and framework synthesis. BMJ Open 10(11):e040634PubMedPubMedCentralCrossRef
14.
go back to reference Raybould G, Babatunde O, Evans A et al (2018) Expressed information needs of patients with osteoporosis and/or fragility fractures: a systematic review. Arch Osteoporos 13(1):55PubMedPubMedCentralCrossRef Raybould G, Babatunde O, Evans A et al (2018) Expressed information needs of patients with osteoporosis and/or fragility fractures: a systematic review. Arch Osteoporos 13(1):55PubMedPubMedCentralCrossRef
15.
go back to reference Maidment I, Lawson S, Wong G et al (2020) Medication management in older people: the MEMORABLE realist synthesis. NIHR Journals Library, Southampton Maidment I, Lawson S, Wong G et al (2020) Medication management in older people: the MEMORABLE realist synthesis. NIHR Journals Library, Southampton
17.
go back to reference Horne R, Cooper V, Wileman V, Chan A (2019) Supporting adherence to medicines for long-term conditions. Eur Psychol 24:82–96CrossRef Horne R, Cooper V, Wileman V, Chan A (2019) Supporting adherence to medicines for long-term conditions. Eur Psychol 24:82–96CrossRef
18.
go back to reference Hayden J, Van der Windt D, Cartwright J et al (2013) Assessing bias in studies of prognostic factors. Ann Intern Med 158(4):280–286PubMedCrossRef Hayden J, Van der Windt D, Cartwright J et al (2013) Assessing bias in studies of prognostic factors. Ann Intern Med 158(4):280–286PubMedCrossRef
19.
go back to reference Tsang J, Blakeman T, Hegarty J et al (2015) Understanding the implementation of interventions to improve the management of chronic kidney disease in primary care: a rapid realist review. Implement Sci 11:47CrossRef Tsang J, Blakeman T, Hegarty J et al (2015) Understanding the implementation of interventions to improve the management of chronic kidney disease in primary care: a rapid realist review. Implement Sci 11:47CrossRef
20.
go back to reference Paskins Z, Jinks C, Mahmood W et al (2017) Public priorities for osteoporosis and fracture research: results from a general population survey. Arch Osteoporos 12(1):45PubMedPubMedCentralCrossRef Paskins Z, Jinks C, Mahmood W et al (2017) Public priorities for osteoporosis and fracture research: results from a general population survey. Arch Osteoporos 12(1):45PubMedPubMedCentralCrossRef
21.
go back to reference Hawarden A, Jinks C, Mahmood W et al (2020) Public priorities for osteoporosis and fracture research: results from a focus group study. Arch Osteoporos 15(1):1–10CrossRef Hawarden A, Jinks C, Mahmood W et al (2020) Public priorities for osteoporosis and fracture research: results from a focus group study. Arch Osteoporos 15(1):1–10CrossRef
22.
go back to reference Bianchi M, Duca P, Vai S et al (2015) Improving adherence to and persistence with oral therapy of osteoporosis. Osteoporos Int 26(5):1629–1638PubMedCrossRef Bianchi M, Duca P, Vai S et al (2015) Improving adherence to and persistence with oral therapy of osteoporosis. Osteoporos Int 26(5):1629–1638PubMedCrossRef
23.
go back to reference Cram P, Wolinsky F, Lou Y et al (2016) Patient-activation and guideline-concordant pharmacological treatment after bone density testing: the PAADRN randomized controlled trial. Osteoporos Int 27(12):3513–3524PubMedPubMedCentralCrossRef Cram P, Wolinsky F, Lou Y et al (2016) Patient-activation and guideline-concordant pharmacological treatment after bone density testing: the PAADRN randomized controlled trial. Osteoporos Int 27(12):3513–3524PubMedPubMedCentralCrossRef
24.
go back to reference Gonnelli S, Caffarelli C, Rossi S et al (2016) How the knowledge of fracture risk might influence adherence to oral therapy of osteoporosis in Italy: the ADEOST study. Aging Clin Exp Res 28:459–468PubMedCrossRef Gonnelli S, Caffarelli C, Rossi S et al (2016) How the knowledge of fracture risk might influence adherence to oral therapy of osteoporosis in Italy: the ADEOST study. Aging Clin Exp Res 28:459–468PubMedCrossRef
25.
go back to reference Liu C, Feasel A, Kline G, Billington E (2021) Pharmacotherapy decisions among postmenopausal women attending a group medical consultation or a one-on-one specialist consultation at an osteoporosis center: an observational cohort study. Osteoporos Int 32(7):1421–1427PubMedCrossRef Liu C, Feasel A, Kline G, Billington E (2021) Pharmacotherapy decisions among postmenopausal women attending a group medical consultation or a one-on-one specialist consultation at an osteoporosis center: an observational cohort study. Osteoporos Int 32(7):1421–1427PubMedCrossRef
26.
go back to reference Oral A, Lorenc R (2015) Compliance, persistence, and preference outcomes of postmenopausal osteoporotic women receiving a flexible or fixed regimen of daily risedronate: A multicenter, prospective, parallel group study. Acta Orthop Traumatol Turc 49(1):67–74PubMed Oral A, Lorenc R (2015) Compliance, persistence, and preference outcomes of postmenopausal osteoporotic women receiving a flexible or fixed regimen of daily risedronate: A multicenter, prospective, parallel group study. Acta Orthop Traumatol Turc 49(1):67–74PubMed
27.
go back to reference Roux S, Beaulieu M, Beaulieu MC et al (2013) Priming primary care physicians to treat osteoporosis after a fragility fracture: an integrated multidisciplinary approach. J Rheumatol 40(5):703–711PubMedCrossRef Roux S, Beaulieu M, Beaulieu MC et al (2013) Priming primary care physicians to treat osteoporosis after a fragility fracture: an integrated multidisciplinary approach. J Rheumatol 40(5):703–711PubMedCrossRef
28.
go back to reference Sagalla N, Lee R, Lyles K et al (2021) Extent of and reasons for osteoporosis medication non-adherence among veterans and feasibility of a pilot text message reminder intervention. Arch Osteoporos 16(1):21PubMedPubMedCentralCrossRef Sagalla N, Lee R, Lyles K et al (2021) Extent of and reasons for osteoporosis medication non-adherence among veterans and feasibility of a pilot text message reminder intervention. Arch Osteoporos 16(1):21PubMedPubMedCentralCrossRef
29.
go back to reference Seuffert P, Sagebien C, McDonnell C et al (2016) Evaluation of osteoporosis risk and initiation of a nurse practitioner intervention program in an orthopedic practice. Arch Osteoporos 11:1CrossRef Seuffert P, Sagebien C, McDonnell C et al (2016) Evaluation of osteoporosis risk and initiation of a nurse practitioner intervention program in an orthopedic practice. Arch Osteoporos 11:1CrossRef
30.
go back to reference Temachika S, Sasaki K, Hayami Y (2018) Patient satisfaction and efficacy of switching from weekly bisphosphonates to monthly minodronate for treatment and prevention of glucocorticoid-induced osteoporosis in Japanese patients with systemic rheumatic diseases: a randomized, clinical trial. Arch Osteoporos 13:67CrossRef Temachika S, Sasaki K, Hayami Y (2018) Patient satisfaction and efficacy of switching from weekly bisphosphonates to monthly minodronate for treatment and prevention of glucocorticoid-induced osteoporosis in Japanese patients with systemic rheumatic diseases: a randomized, clinical trial. Arch Osteoporos 13:67CrossRef
31.
go back to reference Wilton-Clark M, Feasel L, Kline G, O’Billington E (2020) Autonomy begets adherence: decisions to start and persist with osteoporosis treatment after group medical consultation. Arch Osteoporos 15:138PubMedCrossRef Wilton-Clark M, Feasel L, Kline G, O’Billington E (2020) Autonomy begets adherence: decisions to start and persist with osteoporosis treatment after group medical consultation. Arch Osteoporos 15:138PubMedCrossRef
32.
go back to reference Beaton D, Mamdani M, Zheng H et al (2017) Improvements in osteoporosis testing and care are found following the wide scale implementation of the Ontario Fracture Clinic Screening Program: an interrupted time series analysis. Medicine 96:48CrossRef Beaton D, Mamdani M, Zheng H et al (2017) Improvements in osteoporosis testing and care are found following the wide scale implementation of the Ontario Fracture Clinic Screening Program: an interrupted time series analysis. Medicine 96:48CrossRef
33.
go back to reference Ducoulombier V, Luraschi H, Forzy G et al (2015) Contribution of phone follow-up to improved adherence to oral osteoporosis treatment. Am J Pharm Benefits 7(3):e81–e89 Ducoulombier V, Luraschi H, Forzy G et al (2015) Contribution of phone follow-up to improved adherence to oral osteoporosis treatment. Am J Pharm Benefits 7(3):e81–e89
34.
go back to reference Ganda K, Schaffer A, Pearson Seibel MJ (2014) Compliance and persistence to oral bisphosphonate therapy following initiation within a secondary fracture prevention program: a randomised controlled trial of specialist vs. non-specialist management. Osteoporos Int 25(4):1345–1355PubMedCrossRef Ganda K, Schaffer A, Pearson Seibel MJ (2014) Compliance and persistence to oral bisphosphonate therapy following initiation within a secondary fracture prevention program: a randomised controlled trial of specialist vs. non-specialist management. Osteoporos Int 25(4):1345–1355PubMedCrossRef
35.
go back to reference Makras P, Babis G, Chronopoulos E et al (2020) Experience gained from the implementation of the fracture liaison service in Greece. Arch Osteoporos 15:12PubMedCrossRef Makras P, Babis G, Chronopoulos E et al (2020) Experience gained from the implementation of the fracture liaison service in Greece. Arch Osteoporos 15:12PubMedCrossRef
36.
go back to reference McAlister F, Ye C, Beaupre L et al (2019) Adherence to osteoporosis therapy after an upper extremity fracture: a pre-specified substudy of the C-STOP randomized controlled trial. Osteoporos Int 30:127–134PubMedCrossRef McAlister F, Ye C, Beaupre L et al (2019) Adherence to osteoporosis therapy after an upper extremity fracture: a pre-specified substudy of the C-STOP randomized controlled trial. Osteoporos Int 30:127–134PubMedCrossRef
37.
go back to reference Scholten D, Bray J, Wang K et al (2020) Implementation of a fracture liaison service and its effects on osteoporosis treatment adherence and secondary fracture at a tertiary care academic health system. Arch Osteoporos 15(1):80PubMedCrossRef Scholten D, Bray J, Wang K et al (2020) Implementation of a fracture liaison service and its effects on osteoporosis treatment adherence and secondary fracture at a tertiary care academic health system. Arch Osteoporos 15(1):80PubMedCrossRef
38.
go back to reference Senay A, Fernandes J, Delisle J et al (2019) Persistence and compliance to osteoporosis therapy in a fracture liaison service: a prospective cohort study. Arch Osteoporos 14(1):1–11CrossRef Senay A, Fernandes J, Delisle J et al (2019) Persistence and compliance to osteoporosis therapy in a fracture liaison service: a prospective cohort study. Arch Osteoporos 14(1):1–11CrossRef
39.
go back to reference Van den Berg P, Van Haard P, Van der Veer E et al (2018) A dedicated Fracture Liaison Service telephone program and use of bone turnover markers for evaluating 1-year persistence with oral bisphosphonates. Osteoporos Int 29(4):813–824PubMedCrossRef Van den Berg P, Van Haard P, Van der Veer E et al (2018) A dedicated Fracture Liaison Service telephone program and use of bone turnover markers for evaluating 1-year persistence with oral bisphosphonates. Osteoporos Int 29(4):813–824PubMedCrossRef
40.
go back to reference Danila M, Outman R, Rahn E et al (2018) Evaluation of a multimodal, direct-to-patient educational intervention targeting barriers to osteoporosis care: a randomized clinical trial. J Bone Miner Res 33(5):763–772PubMedCrossRef Danila M, Outman R, Rahn E et al (2018) Evaluation of a multimodal, direct-to-patient educational intervention targeting barriers to osteoporosis care: a randomized clinical trial. J Bone Miner Res 33(5):763–772PubMedCrossRef
41.
go back to reference Hitz M, Arup S, Holm J et al (2020) Outcome of osteoporosis evaluation, treatment, and follow-up in patients referred to a specialized outpatient clinic compared to patients in care of general practitioners. Arch Osteoporos 15(1):1–11CrossRef Hitz M, Arup S, Holm J et al (2020) Outcome of osteoporosis evaluation, treatment, and follow-up in patients referred to a specialized outpatient clinic compared to patients in care of general practitioners. Arch Osteoporos 15(1):1–11CrossRef
42.
go back to reference LeBlanc A, Wang T, Wyatt K et al (2015) Encounter decision aid vs. clinical decision support or usual care to support patient-centered treatment decisions in osteoporosis: the osteoporosis choice randomized trial II. PLoS One 10(5):e0128063PubMedPubMedCentralCrossRef LeBlanc A, Wang T, Wyatt K et al (2015) Encounter decision aid vs. clinical decision support or usual care to support patient-centered treatment decisions in osteoporosis: the osteoporosis choice randomized trial II. PLoS One 10(5):e0128063PubMedPubMedCentralCrossRef
43.
go back to reference Leslie W, Morin S, Martineau P et al (2019) Association of bone density monitoring in routine clinical practice with anti-osteoporosis medication use and incident fractures: a matched cohort study. J Bone Miner Res 34(10):1808–1814PubMedCrossRef Leslie W, Morin S, Martineau P et al (2019) Association of bone density monitoring in routine clinical practice with anti-osteoporosis medication use and incident fractures: a matched cohort study. J Bone Miner Res 34(10):1808–1814PubMedCrossRef
44.
go back to reference Parsons C, Harvey N, Shepstone L et al (2020) Systematic screening using FRAX® leads to increased use of, and adherence to, anti-osteoporosis medications: an analysis of the UK SCOOP trial. Osteoporos Int 31(1):67–75PubMedCrossRef Parsons C, Harvey N, Shepstone L et al (2020) Systematic screening using FRAX® leads to increased use of, and adherence to, anti-osteoporosis medications: an analysis of the UK SCOOP trial. Osteoporos Int 31(1):67–75PubMedCrossRef
45.
go back to reference Stuurman-Bieze A, Hiddink E, Van Boven J, Vegter S (2014) Proactive pharmaceutical care interventions decrease patients’ nonadherence to osteoporosis medication. Osteoporos Int 25(6):1807–1812PubMed Stuurman-Bieze A, Hiddink E, Van Boven J, Vegter S (2014) Proactive pharmaceutical care interventions decrease patients’ nonadherence to osteoporosis medication. Osteoporos Int 25(6):1807–1812PubMed
46.
go back to reference Tüzün Ş, Akyüz G, Eskiyurt N et al (2013) Impact of the training on the compliance and persistence of weekly bisphosphonate treatment in postmenopausal osteoporosis: a randomized controlled study. Int J Med Sci 10(13):1880PubMedPubMedCentralCrossRef Tüzün Ş, Akyüz G, Eskiyurt N et al (2013) Impact of the training on the compliance and persistence of weekly bisphosphonate treatment in postmenopausal osteoporosis: a randomized controlled study. Int J Med Sci 10(13):1880PubMedPubMedCentralCrossRef
47.
go back to reference Van Maren M, Wyers C, Driessen J et al (2019) Two-year persistence with teriparatide improved significantly after introduction of an educational and motivational support program. Osteoporos Int 30(9):1837–1844PubMedPubMedCentralCrossRef Van Maren M, Wyers C, Driessen J et al (2019) Two-year persistence with teriparatide improved significantly after introduction of an educational and motivational support program. Osteoporos Int 30(9):1837–1844PubMedPubMedCentralCrossRef
48.
go back to reference Montori V, Shah N, Pencille L et al (2011) Use of a decision aid to improve treatment decisions in osteoporosis: the osteoporosis choice randomized trial. Am J med 124(6):549–556PubMedCrossRef Montori V, Shah N, Pencille L et al (2011) Use of a decision aid to improve treatment decisions in osteoporosis: the osteoporosis choice randomized trial. Am J med 124(6):549–556PubMedCrossRef
49.
go back to reference Baqir W, Gray W, Blair A et al (2020) Osteoporosis group consultations are as effective as usual care: results from a non-inferiority randomized trial. Lifestyle Med 1(1):e3CrossRef Baqir W, Gray W, Blair A et al (2020) Osteoporosis group consultations are as effective as usual care: results from a non-inferiority randomized trial. Lifestyle Med 1(1):e3CrossRef
50.
go back to reference Salter C, McDaid L, Bhattacharya D et al (2014) Abandoned acid? Understanding adherence to bisphosphonate medications for the prevention of osteoporosis among older women: a qualitative longitudinal study. PLoS ONE 2(9):1 Salter C, McDaid L, Bhattacharya D et al (2014) Abandoned acid? Understanding adherence to bisphosphonate medications for the prevention of osteoporosis among older women: a qualitative longitudinal study. PLoS ONE 2(9):1
51.
go back to reference Shepstone L, Lenaghan E, Cooper C et al (2018) Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial. Lancet 391(10122):741–747PubMedCrossRef Shepstone L, Lenaghan E, Cooper C et al (2018) Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial. Lancet 391(10122):741–747PubMedCrossRef
52.
go back to reference Cizmic A, Heilmann R, Milchak J et al (2015) Impact of interactive voice response technology on primary adherence to bisphosphonate therapy: a randomized controlled trial. Osteoporos Int 26:2131–2136PubMedCrossRef Cizmic A, Heilmann R, Milchak J et al (2015) Impact of interactive voice response technology on primary adherence to bisphosphonate therapy: a randomized controlled trial. Osteoporos Int 26:2131–2136PubMedCrossRef
53.
go back to reference Spence M, Makarem A, Reyes S, Nguyen C (2017) Evaluation of an outpatient pharmacy clinical services program on adherence and fractures among patients with osteoporosis. J Contemp Pharm Pract 64(3):8–14CrossRef Spence M, Makarem A, Reyes S, Nguyen C (2017) Evaluation of an outpatient pharmacy clinical services program on adherence and fractures among patients with osteoporosis. J Contemp Pharm Pract 64(3):8–14CrossRef
54.
go back to reference Nho JH, Lee YK, Ha YC et al (2016) Can alarming improve compliance with weekly bisphosphonate in patients with osteoporosis? J Bone Metab 23(2):51–54PubMedPubMedCentralCrossRef Nho JH, Lee YK, Ha YC et al (2016) Can alarming improve compliance with weekly bisphosphonate in patients with osteoporosis? J Bone Metab 23(2):51–54PubMedPubMedCentralCrossRef
55.
go back to reference Delmas P, Vrijens B, Eastell R et al (2007) Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis. J Clin Endocrinol Metab 92:1296–1304PubMedCrossRef Delmas P, Vrijens B, Eastell R et al (2007) Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis. J Clin Endocrinol Metab 92:1296–1304PubMedCrossRef
56.
go back to reference Clowes J, Peel N, Eastell R (2004) The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial. J Clin Endocrinol Metab 89:1117–1123PubMedCrossRef Clowes J, Peel N, Eastell R (2004) The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial. J Clin Endocrinol Metab 89:1117–1123PubMedCrossRef
57.
go back to reference Silverman S, Nasser K, Nattrass S et al (2012) Impact of bone turnover markers and/or educational information on persistence to oral bisphosphonate therapy: a community setting-based trial. Osteoporos Int 23:1069–1074PubMedCrossRef Silverman S, Nasser K, Nattrass S et al (2012) Impact of bone turnover markers and/or educational information on persistence to oral bisphosphonate therapy: a community setting-based trial. Osteoporos Int 23:1069–1074PubMedCrossRef
58.
go back to reference Iglay K, Cao X, Mavros P et al (2015) Systematic literature review and meta-analysis of medication adherence with once-weekly versus once-daily therapy. Clin Ther 37(8):1813–1821PubMedCrossRef Iglay K, Cao X, Mavros P et al (2015) Systematic literature review and meta-analysis of medication adherence with once-weekly versus once-daily therapy. Clin Ther 37(8):1813–1821PubMedCrossRef
59.
go back to reference Van Boven J, Stuurman-Bieze A, Hiddink E et al (2014) Medication monitoring and optimization: a targeted pharmacist program for effective and cost-effective improvement of chronic therapy adherence. J Manag Care Spec Pharm 20(8):786–792PubMed Van Boven J, Stuurman-Bieze A, Hiddink E et al (2014) Medication monitoring and optimization: a targeted pharmacist program for effective and cost-effective improvement of chronic therapy adherence. J Manag Care Spec Pharm 20(8):786–792PubMed
60.
go back to reference Hui N, Fraser S, Wong P (2020) Patients discharged from a fracture liaison service still require follow-up and bone health advice. Arch Osteoporos 15:118PubMedCrossRef Hui N, Fraser S, Wong P (2020) Patients discharged from a fracture liaison service still require follow-up and bone health advice. Arch Osteoporos 15:118PubMedCrossRef
61.
go back to reference Emmel N, Greenhalgh J, Manzano A et al eds (2018) Doing realist research. Sage, London Emmel N, Greenhalgh J, Manzano A et al eds (2018) Doing realist research. Sage, London
62.
go back to reference Thakkar J, Kurup R, Laba T et al (2016) Mobile telephone text messaging for medication adherence in chronic disease: a meta-analysis. JAMA Intern Med 176(3):340–349PubMedCrossRef Thakkar J, Kurup R, Laba T et al (2016) Mobile telephone text messaging for medication adherence in chronic disease: a meta-analysis. JAMA Intern Med 176(3):340–349PubMedCrossRef
63.
go back to reference Berkman N, Sheridan S, Donahue K et al (2011) Low health literacy and health outcomes: an updated systematic review. Ann Intern Med 155(2):97–107PubMedCrossRef Berkman N, Sheridan S, Donahue K et al (2011) Low health literacy and health outcomes: an updated systematic review. Ann Intern Med 155(2):97–107PubMedCrossRef
64.
go back to reference Majumdar S, Lier D, McAlister F et al (2019) Cost-effectiveness of osteoporosis interventions to improve quality of care after upper extremity fracture: results from a randomized trial (C-STOP Trial. J Bone Miner Res 34(7):1220–1228PubMedCrossRef Majumdar S, Lier D, McAlister F et al (2019) Cost-effectiveness of osteoporosis interventions to improve quality of care after upper extremity fracture: results from a randomized trial (C-STOP Trial. J Bone Miner Res 34(7):1220–1228PubMedCrossRef
65.
go back to reference NICE (2021) Shared Decision Making. National Institute for Health and Care Excellence, London NICE (2021) Shared Decision Making. National Institute for Health and Care Excellence, London
66.
go back to reference Hoffmann T, Glasziou P, Boutron I et al (2014) Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ 348:g1687PubMedCrossRef Hoffmann T, Glasziou P, Boutron I et al (2014) Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ 348:g1687PubMedCrossRef
Metadata
Title
Supporting patients to get the best from their osteoporosis treatment: a rapid realist review of what works, for whom, and in what circumstance
Authors
Z. Paskins
O. Babatunde
A. Sturrock
L. S. Toh
R. Horne
I. Maidment
on behalf of the Effectiveness Working Group of the Royal Osteoporosis Society Osteoporosis, Bone Research Academy
Publication date
11-06-2022
Publisher
Springer London
Published in
Osteoporosis International / Issue 11/2022
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-022-06453-4

Other articles of this Issue 11/2022

Osteoporosis International 11/2022 Go to the issue